FA
PPBT

Fiduciary Alliance’s Purple Biotech PPBT Stock Holding History

Fiduciary Alliance’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-27
Closed -$7.55K – 736
2023
Q2 		$7.55K Buy
+27
New +$9.69K ﹤0.01% 622
2023
Q1 		– Sell
-16
Closed -$4.49K – 673
2022
Q4 		$4.49K Buy
+16
New +$6.14K ﹤0.01% 558

Other funds holding PPBT

KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VVP
Venture Visionary Partners Sylvania, Ohio $3.6B AUM 30.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WAOI
Wealth Advisors of Iowa West Des Moines, Iowa $369M AUM 18.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Fiduciary Alliance's PPBT Position: Q3 2023 in Review

Fiduciary Alliance sold out of Purple Biotech (PPBT) in Q3 2023, closing a stake of 27 shares — an estimated $7.55K sold.

Fiduciary Alliance first reported a position in PPBT in Q4 2022 and held it in 2 quarters. The position peaked at $7.55K in Q2 2023. 16 funds tracked by Wall St. Rank hold PPBT as of Q3 2023.

  • Fiduciary Alliance reported no remaining Purple Biotech position as of Q3 2023 after selling out during the quarter.
  • Fiduciary Alliance sold 27 Purple Biotech shares in Q3 2023, an estimated $7.55K.
  • Fiduciary Alliance first reported a position in Purple Biotech in Q4 2022 and held it in 2 quarters.
  • Fiduciary Alliance's Purple Biotech position peaked at $7.55K in Q2 2023.
  • 16 funds tracked by Wall St. Rank held Purple Biotech as of Q3 2023.

Based on Fiduciary Alliance's 13F filing for Q3 2023, filed 18 Oct 2023.